HIGHLIGHTS
- who: Anna-Maria Barciszewska and colleagues from the Karol Marcinkowski University of Medical Sciences, Przybyszewskiego, Poznan, Poland have published the research: Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line, in the Journal: (JOURNAL)
- what: The study aimed to evaluate the juglone effect alone and in combination with temozolomide on glioblastoma multiforme cells by looking through the epigenetics window. Using combinations of juglone and TMZ at the concentrations mentioned above, the authors show the concomitant effect of that dual treatment.
SUMMARY
Juglone causes cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.